Due to inclement weather, our offices will close at 12pm on Wednesday (2/19), remain closed on Thursday and Friday, and will reopen on Monday (2/24). For more information, please call our inclement weather lines at 757-264-4994 on the Peninsula and 757-264-4990 on the Southside and in Elizabeth City.
2025 UPDATES: Please bring all new insurance cards to your next appointment and verify your address and phone number when you check in at the front desk. 

Virginia Oncology Associates

Virginia Oncology Associates

Clinical Research & Trials

Cancer Center » Clinical Research & Trials » Available Trials » USO 22159

USO 22159

A Phase 3, Open-Label, Randomized, Two-Part Study Comparing Gedatolisib in Combination with Palbociclib and Fulvestrant to Standard-of-Care Therapies in Patients with HR-Positive, HER2-Negative Advanced Breast Cancer Previously Treated with a CDK4/6 Inhibitor in Combination with Non-Steroidal Aromatase Inhibitor Therapy (VIKTORIA-1) (CELC-G-301)

 

Disease Types: Breast Cancer Research

Available at:

Virginia Oncology Associates